C. E. Higgens

991 total citations
9 papers, 765 citations indexed

About

C. E. Higgens is a scholar working on Molecular Biology, Pharmacology and Plant Science. According to data from OpenAlex, C. E. Higgens has authored 9 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Plant Science. Recurrent topics in C. E. Higgens's work include Microbial Natural Products and Biosynthesis (4 papers), Antibiotic Resistance in Bacteria (2 papers) and Alkaloids: synthesis and pharmacology (2 papers). C. E. Higgens is often cited by papers focused on Microbial Natural Products and Biosynthesis (4 papers), Antibiotic Resistance in Bacteria (2 papers) and Alkaloids: synthesis and pharmacology (2 papers). C. E. Higgens collaborates with scholars based in United States. C. E. Higgens's co-authors include Robert L. Hamill, Marvin Gorman, Harold E. Boaz, Renate Kastner, W. Marshall Stark, R. Nagarajan, LaVerne D. Boeck, Joel G. Whitney, Marvin M. Hoehn and M. Hoehn and has published in prestigious journals such as Journal of the American Chemical Society, Tetrahedron Letters and The Journal of Antibiotics.

In The Last Decade

C. E. Higgens

9 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. E. Higgens United States 7 370 346 183 180 112 9 765
G. ALBERS‐SCHOENBERG 5 230 0.6× 203 0.6× 247 1.3× 115 0.6× 59 0.5× 5 603
H Zähner Germany 15 233 0.6× 542 1.6× 240 1.3× 216 1.2× 22 0.2× 34 949
WILLIAM H. TREJO Malaysia 21 476 1.3× 497 1.4× 295 1.6× 217 1.2× 19 0.2× 38 1.1k
Eiji Higashide Japan 17 464 1.3× 497 1.4× 305 1.7× 114 0.6× 20 0.2× 58 938
Robert T. Goegelman United States 10 489 1.3× 312 0.9× 265 1.4× 75 0.4× 45 0.4× 13 866
L. Delcambe France 19 176 0.5× 646 1.9× 120 0.7× 269 1.5× 34 0.3× 33 1.1k
W. Loeffler Germany 11 285 0.8× 524 1.5× 174 1.0× 379 2.1× 46 0.4× 33 1.2k
Prakash Masurekar United States 14 361 1.0× 350 1.0× 121 0.7× 144 0.8× 33 0.3× 27 739
TATSUO HANEISHI Germany 18 549 1.5× 672 1.9× 610 3.3× 162 0.9× 32 0.3× 56 1.3k
Hideaki Ui Japan 20 362 1.0× 552 1.6× 295 1.6× 122 0.7× 55 0.5× 36 1.1k

Countries citing papers authored by C. E. Higgens

Since Specialization
Citations

This map shows the geographic impact of C. E. Higgens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. E. Higgens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. E. Higgens more than expected).

Fields of papers citing papers by C. E. Higgens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. E. Higgens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. E. Higgens. The network helps show where C. E. Higgens may publish in the future.

Co-authorship network of co-authors of C. E. Higgens

This figure shows the co-authorship network connecting the top 25 collaborators of C. E. Higgens. A scholar is included among the top collaborators of C. E. Higgens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. E. Higgens. C. E. Higgens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Boeck, LaVerne D., et al.. (1984). N-demethylvancomycin, a novel antibiotic produced by a strain of Nocardia orientalis. Taxonomy and fermentation.. The Journal of Antibiotics. 37(5). 446–453. 24 indexed citations
2.
MERTZ, FREDERICK P. & C. E. Higgens. (1982). Streptomyces capillispiralis sp. nov.. International Journal of Systematic Bacteriology. 32(1). 116–124. 3 indexed citations
3.
Nagarajan, R., et al.. (1974). Deacetoxycephalosporin C from Streptomyces and fungi. Journal of the Chemical Society Chemical Communications. 321–321. 2 indexed citations
4.
Higgens, C. E., et al.. (1974). THE OCCURRENCE OF DEACETOXY-CEPHALOSPORIN C IN FUNGI AND STREPTOMYCETES. The Journal of Antibiotics. 27(4). 298–300. 59 indexed citations
5.
Daily, William A. & C. E. Higgens. (1973). Preservation and storage of microorganisms in the gas phase of liquid nitrogen. Cryobiology. 10(5). 364–367. 26 indexed citations
6.
Higgens, C. E. & Renate Kastner. (1971). Streptomyces clavuligerus sp. nov., a  -Lactam Antibiotic Producer. International Journal of Systematic Bacteriology. 21(4). 326–331. 91 indexed citations
7.
Nagarajan, R., LaVerne D. Boeck, Marvin Gorman, et al.. (1971). .beta.-Lactam antibiotics from Streptomyces. Journal of the American Chemical Society. 93(9). 2308–2310. 191 indexed citations
8.
Hamill, Robert L., C. E. Higgens, Harold E. Boaz, & Marvin Gorman. (1969). The structure op beauvericin, a new depsipeptide antibiotic toxic to. Tetrahedron Letters. 10(49). 4255–4258. 295 indexed citations
9.
McGuire, J. M., et al.. (1961). Tylosin, a New Antibiotic : I. Microbiological Studies.. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 11(5). 320–327. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026